Click here to see an annotated bibliography of the data in the table.
This is a table of authors, titles, dates and other bibliographic information; it is a list metadata describing the content of your study carrel. Think of it as your library.
| id | author | title | date | words | sentences | text |
|---|---|---|---|---|---|---|
| cord-256118-gxhhwqdd | Abadie, R. | “Caballo”: risk environments, drug sharing and the emergence of a hepatitis C virus epidemic among people who inject drugs in Puerto Rico | 2020-10-23 | 7854.0 | 337.0 | view text |
| cord-280819-z6ucnwk0 | Achilonu, Ikechukwu | Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 α-ketoamide derivative and Pentagastrin: an in-silico drug discovery approach | 2020-09-02 | nan | nan | view text |
| cord-255460-r5p5helx | Aggarwal, Sadhna | Drug repurposing for breast cancer therapy: Old weapon for new battle | 2019-09-21 | nan | nan | view text |
| cord-304617-5ozf18lg | Al-Khafaji, Khattab | Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2 | 2020-05-15 | nan | nan | view text |
| cord-263840-1t4ykc01 | Altay, Ozlem | Current status of COVID-19 therapies and drug repositioning applications | 2020-06-20 | 2099.0 | 140.0 | view text |
| cord-283956-zgrtux7i | Amin, Sk. Abdul | Fight against novel coronavirus: A perspective of medicinal chemists | 2020-06-12 | nan | nan | view text |
| cord-321741-aq76s37x | Andersen, Petter I. | Discovery and development of safe-in-man broad-spectrum antiviral agents | 2020-04-30 | 5432.0 | 308.0 | view text |
| cord-318048-6nvi63rq | Arshad, Usman | Prioritisation of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics | 2020-05-21 | 5663.0 | 288.0 | view text |
| cord-314827-yqr7110e | Attia, Yasmeen M. | Successful stories of drug repurposing for cancer therapy in hepatocellular carcinoma | 2020-09-04 | 6483.0 | 300.0 | view text |
| cord-297010-imciixde | Babayeva, Mariana | Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine | 2020-10-23 | 7080.0 | 519.0 | view text |
| cord-332271-slouuryl | Baker, Jeremy D. | A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease | 2020-08-27 | nan | nan | view text |
| cord-345059-t6hojshj | Bayoumy, A. B. | Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian’s perspective | 2020-07-17 | nan | nan | view text |
| cord-311730-189vax2m | Becker, Richard C. | Covid-19 treatment update: follow the scientific evidence | 2020-04-27 | 4514.0 | 222.0 | view text |
| cord-016460-39yniw0t | Ben-Chetrit, Eldad | Colchicine | 2018-07-31 | nan | nan | view text |
| cord-325019-hznnoxw6 | Benavides-Cordoba, Vicente | Drug Repositioning for COVID-19 | 2020-06-30 | nan | nan | view text |
| cord-333122-xw8o189s | Blasiak, A. | IDentif.AI: Artificial Intelligence Pinpoints Remdesivir in Combination with Ritonavir and Lopinavir as an Optimal Regimen Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | 2020-05-08 | nan | nan | view text |
| cord-303089-fbxtj8ij | Boccaletti, Valeria | Acute generalized exanthematous pustulosis following paracetamol ingestion in a child | 2015-05-24 | nan | nan | view text |
| cord-274307-kl0uvrbw | Bordet, Régis | Is the drug a scientific, social or political object? | 2020-05-23 | nan | nan | view text |
| cord-316029-z708c3ex | Brunsdon, Priya | Clinical Pharmacology Considerations for Developing Small‐Molecule Treatments for COVID‐19 | 2020-07-12 | 4964.0 | 264.0 | view text |
| cord-351185-3y3gou6v | Buckles, Thomas C. | Rapid exposure of macrophages to drugs resolves four classes of effects on the leading edge sensory pseudopod: Non-perturbing, adaptive, disruptive, and activating | 2020-05-29 | 10061.0 | 465.0 | view text |
| cord-016309-6mw8okmt | Bule, Mohammed | Antivirals: Past, Present and Future | 2019-06-06 | 8200.0 | 405.0 | view text |
| cord-342588-berrojmq | Burri, Christian | Sleeping Sickness at the Crossroads | 2020-04-08 | nan | nan | view text |
| cord-273656-xo82zyi6 | Burry, Lisa D. | It Takes a Village… Contending with Drug Shortages During Disasters | 2020-08-14 | nan | nan | view text |
| cord-015684-q10sx1dm | Cacabelos, Ramón | Pharmacogenomic Biomarkers in Neuropsychiatry: The Path to Personalized Medicine in Mental Disorders | 2009 | nan | nan | view text |
| cord-323940-ubazgvov | Cafiero, Concetta | Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease | 2020-10-13 | nan | nan | view text |
| cord-203232-1nnqx1g9 | Canturk, Semih | Machine-Learning Driven Drug Repurposing for COVID-19 | 2020-06-25 | 5023.0 | 257.0 | view text |
| cord-302018-3rlya16w | Castells, Mariana C. | Drug allergy labeling and delabeling in the coronavirus disease 2019 era: What is important and what do we need to know | 2020-05-22 | 1939.0 | 97.0 | view text |
| cord-285121-3cjr1rol | Chan, Marion M. | Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations | 2018-10-01 | nan | nan | view text |
| cord-273941-gu6nnv9d | Chandran, Uma | Chapter 5 Network Pharmacology | 2017-12-31 | nan | nan | view text |
| cord-267608-0odu8lus | Chen, Daohong | Innovative highlights of clinical drug trial design | 2020-06-03 | 4164.0 | 155.0 | view text |
| cord-004501-guiy89x8 | Cojocaru, Florina-Daniela | Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers | 2020-02-18 | nan | nan | view text |
| cord-023509-tvqpv6fp | Corrin, Bryan | Occupational, environmental and iatrogenic lung disease | 2011-03-02 | 42576.0 | 2457.0 | view text |
| cord-018714-i291z2ju | Criado, Paulo Ricardo | Adverse Drug Reactions | 2016-12-31 | nan | nan | view text |
| cord-347579-aqgauumt | Csete, Joanne | United States drug courts and opioid agonist therapy: Missing the target of overdose reduction | 2020-06-09 | 4141.0 | 173.0 | view text |
| cord-343620-64i1balq | Darvishi, Behrad | Preparation and Antibacterial Activity Evaluation of 18-β-glycyrrhetinic Acid Loaded PLGA Nanoparticles | 2015 | nan | nan | view text |
| cord-301026-spgidqh3 | Das, Shaoli | In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data | 2020-06-30 | nan | nan | view text |
| cord-321267-ihd30qi0 | Daughton, Christian G. | Natural experiment concept to accelerate the Re-purposing of existing therapeutics for Covid-19 | 2020-05-15 | nan | nan | view text |
| cord-288026-vcp8o5xn | DeStefano, Vincent | Applications of PLA in Modern Medicine | 2020-09-06 | 8592.0 | 612.0 | view text |
| cord-322915-zrjx31ev | Demain, Arnold L | Microbial drug discovery: 80 years of progress | 2009-01-09 | 11246.0 | 688.0 | view text |
| cord-303555-mwu72q7w | Dent, Paul | Cell Signaling and Translational Developmental Therapeutics | 2020-10-06 | 8877.0 | 556.0 | view text |
| cord-017583-72mbsib7 | Devarajan, Padma V. | Infectious Diseases: Need for Targeted Drug Delivery | 2014-09-01 | 8877.0 | 531.0 | view text |
| cord-260215-gsnjlhjd | Dhanani, Jayesh | Fundamentals of aerosol therapy in critical care | 2016-10-07 | nan | nan | view text |
| cord-334881-x9nxxled | Di Lorenzo, Giuseppe | COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature | 2020-05-21 | 3248.0 | 186.0 | view text |
| cord-018595-x3tleomb | Dodiuk-Gad, Roni P. | Adverse Medication Reactions | 2017-04-25 | 16304.0 | 910.0 | view text |
| cord-298033-kzdp9edn | Domingo, Esteban | Quasispecies dynamics in disease prevention and control | 2019-11-08 | 16346.0 | 735.0 | view text |
| cord-252147-bvtchcbt | Domingo-Espín, Joan | Engineered Biological Entities for Drug Delivery and Gene Therapy: Protein Nanoparticles | 2011-11-15 | nan | nan | view text |
| cord-321657-2s1npse5 | Du, Sean Quan | Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis | 2020-05-13 | 6461.0 | 294.0 | view text |
| cord-322885-ob5euspo | Durdagi, Serdar | Near-Physiological-Temperature Serial Femtosecond X-ray Crystallography Reveals Novel Conformations of SARS-CoV-2 Main Protease Active Site for Improved Drug Repurposing | 2020-09-09 | 10818.0 | 656.0 | view text |
| cord-353524-3w970ycx | Dömling, Alexander | Chemistry and Biology of SARS-CoV-2 | 2020-05-22 | 3942.0 | 237.0 | view text |
| cord-252166-qah877pk | Ekins, S | In silico pharmacology for drug discovery: applications to targets and beyond | 2007-09-01 | nan | nan | view text |
| cord-299911-v95pf3eg | El-Ghiaty, Mahmoud A. | Cytochrome P450-mediated drug interactions in COVID-19 patients: current findings and possible mechanisms | 2020-06-26 | 5319.0 | 272.0 | view text |
| cord-334511-lx9608vy | Emwas, Abdul-Hamid | NMR as a “Gold Standard” Method in Drug Design and Discovery | 2020-10-09 | 29224.0 | 1507.0 | view text |
| cord-001244-qdld7hdc | Fan, Yue-Nong | iNR-Drug: Predicting the Interaction of Drugs with Nuclear Receptors in Cellular Networking | 2014-03-19 | 6502.0 | 339.0 | view text |
| cord-283287-073r80s7 | Farhoudian, Ali | COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper | 2020-04-12 | nan | nan | view text |
| cord-351517-npcuo1ld | Gale, Robert Peter | Liaisons Dangereuses? new drugs, physicians and the drug industry | 2020-07-01 | nan | nan | view text |
| cord-261170-arnwk287 | Gallimore, W. | Chapter 18 Marine Metabolites Oceans of Opportunity | 2017-12-31 | nan | nan | view text |
| cord-017702-v46ye328 | Ganguly, Nirmal Kumar | Pharmacogenomics and Personalized Medicine for Infectious Diseases | 2013-06-11 | nan | nan | view text |
| cord-329881-9vnz5zzg | Garcia, Sònia | Pandemics and Traditional Plant-Based Remedies. A Historical-Botanical Review in the Era of COVID19 | 2020-08-28 | nan | nan | view text |
| cord-284479-75zgljet | García-Serradilla, Moisés | Drug repurposing for new, efficient, broad spectrum antivirals | 2019-04-15 | nan | nan | view text |
| cord-325473-hrdanbn1 | Ghahremanpour, Mohammad M. | Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2 | 2020-08-28 | nan | nan | view text |
| cord-257344-d13at1y5 | Ghasemiyeh, Parisa | COVID-19 Outbreak: Challenges in Pharmacotherapy Based on Pharmacokinetic and Pharmacodynamic Aspects of Drug Therapy in Patients with Moderate to Severe Infection | 2020-09-18 | nan | nan | view text |
| cord-303865-vd3qr32o | Gianturco, Stephanie L. | Outsourcing facilities and their place in the U.S. drug supply chain | 2020-08-28 | nan | nan | view text |
| cord-007511-5d5authn | Gil, JP | CYP2C8 and antimalaria drug efficacy | 2007-02-07 | 6628.0 | 363.0 | view text |
| cord-257144-3q0un5rl | Giri, Allan | Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19 | 2020-09-02 | nan | nan | view text |
| cord-355971-99mhacqa | Gougis, Paul | Anticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use? | 2020-06-10 | 761.0 | 63.0 | view text |
| cord-022082-1dq623oe | Greaves, Peter | Respiratory Tract | 2007-09-28 | nan | nan | view text |
| cord-320172-qw47pf9r | Greaves, Peter | VII Digestive System 1 | 2000-12-31 | 47375.0 | 2238.0 | view text |
| cord-299225-exbdg3x9 | Guarnieri, Michael | A Long-Term Study of a Lipid-Buprenorphine Implant in Rats | 2018-07-09 | 2662.0 | 159.0 | view text |
| cord-324660-w81jgw7p | Guharoy, Roy | Medication Shortages: A Matter of National Security—Time for Action | 2020-08-01 | 1105.0 | 56.0 | view text |
| cord-203191-7ftg6bfx | Guo, Kai | Identification of Repurposal Drugs and Adverse Drug Reactions for Various Courses of Coronavirus Disease 2019 (COVID-19) Based on Single-cell RNA Sequencing Data | 2020-05-16 | 3729.0 | 184.0 | view text |
| cord-329318-eo8auo1f | Gusarov, Sergey | COSMO-RS-Based Descriptors for the Machine Learning-Enabled Screening of Nucleotide Analogue Drugs against SARS-CoV-2 | 2020-10-26 | 3971.0 | 217.0 | view text |
| cord-255895-6at9gelt | Han, Namshik | Identification of SARS-CoV-2 induced pathways reveal drug repurposing strategies | 2020-08-25 | nan | nan | view text |
| cord-016283-b6yywn9f | Hasan, Ashfaq | Clinical Aspects and Principles of Management of Tuberculosis | 2019-08-07 | 6930.0 | 347.0 | view text |
| cord-000182-ni6iyzdn | He, Zhisong | Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features | 2010-03-11 | 6037.0 | 305.0 | view text |
| cord-316792-89f8g0m8 | Herzig, Volker | Animal toxins — Nature’s evolutionary-refined toolkit for basic research and drug discovery | 2020-06-12 | 12747.0 | 631.0 | view text |
| cord-257496-mirh80gn | Hickey, Anthony J. | Emerging trends in inhaled drug delivery | 2020-07-12 | 4689.0 | 258.0 | view text |
| cord-294582-flkjekyo | Hijikata, Atsushi | Knowledge‐based structural models of SARS‐CoV‐2 proteins and their complexes with potential drugs | 2020-05-25 | nan | nan | view text |
| cord-104431-3rblzyry | Hill, Andrew | Minimum costs to manufacture new treatments for COVID-19 | 2020-04-30 | 5494.0 | 336.0 | view text |
| cord-280158-3fhhuzg5 | Hoffman, Paul S. | Antibacterial Discovery: 21st Century Challenges | 2020-04-28 | nan | nan | view text |
| cord-001072-pjv3wy80 | Hong, Xiaoyun | Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine | 2013-09-04 | 4118.0 | 196.0 | view text |
| cord-274401-pjyvg53w | Hrkach, Jeff | From micro to nano: evolution and impact of drug delivery in treating disease | 2020-05-08 | nan | nan | view text |
| cord-268283-eja8fkwv | Iftikhar, Hafsa | Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach | 2020-06-09 | nan | nan | view text |
| cord-257318-jejgkcql | Jain, K.K. | Synthetic Biology and Personalized Medicine | 2012-08-16 | nan | nan | view text |
| cord-275772-pmf6stua | Jourdan, Jean‐Pierre | Drug repositioning: a brief overview | 2020-04-17 | 3239.0 | 160.0 | view text |
| cord-035236-7rfc73qb | Karabasz, Alicja | Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature | 2020-11-06 | nan | nan | view text |
| cord-104493-yqf7tyo4 | Keshmiri Neghab, Hoda | Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19 | 2020 | nan | nan | view text |
| cord-278362-pwi48i20 | Khan, Abbas | Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro) | 2020-06-18 | nan | nan | view text |
| cord-263874-q0egnzwf | Khan, Md. Arif | Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study | 2020-07-22 | nan | nan | view text |
| cord-273716-vv3pyft4 | Khosravi-Darani, Kianoush | The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy | 2007-07-03 | 10230.0 | 514.0 | view text |
| cord-302947-flgwxc57 | Kipshidze, Nicholas | Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review | 2020-09-16 | nan | nan | view text |
| cord-266294-ua22udlc | Koch, Oliver | 29 Antiviral drugs | 2010-12-31 | nan | nan | view text |
| cord-001151-mdej7nhj | Kumar De, Amit | Application of an Amine Functionalized Biopolymer in the Colonic Delivery of Glycyrrhizin: A Design and In Vivo Efficacy Study | 2013-05-18 | 5109.0 | 271.0 | view text |
| cord-324166-6ydn2bvy | Kumar, Neeraj | Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis | 2020-08-20 | nan | nan | view text |
| cord-275827-r86ygqmy | Lapeyre-Mestre, Maryse | Addictovigilance contribution during COVID-19 epidemic and lockdown in France | 2020-06-23 | nan | nan | view text |
| cord-349794-mhviub6e | Le, Brian L. | Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19 | 2020-10-23 | 3810.0 | 216.0 | view text |
| cord-328559-2qvxw896 | LeSaint, Kathy T. | Impact of Social Distancing on Individuals Who Use Drugs: Considerations for Emergency Department Providers | 2020-08-18 | nan | nan | view text |
| cord-347986-ds5hm731 | Lee, Paul J. | Developing Infectious Disease Strategies for the Developing World | 2007-01-26 | 4102.0 | 193.0 | view text |
| cord-272060-o0wx0add | Li, Allen | Drug-drug interactions affecting drug levels of direct oral anticoagulants in the real world: A systematic review() | 2020-08-11 | nan | nan | view text |
| cord-270622-aofva2ab | Li, Qizhang | Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2 | 2020-08-26 | nan | nan | view text |
| cord-354445-lnvc7mmf | Lichtenstein, David | 4 Cleaning and Disinfecting Gastrointestinal Endoscopy Equipment | 2019-12-31 | 13656.0 | 833.0 | view text |
| cord-291180-xurmzmwj | Lin, Xiaoqian | A Review on Applications of Computational Methods in Drug Screening and Design | 2020-03-18 | nan | nan | view text |
| cord-032561-x3qbqy69 | Liu, Gengqi | Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment | 2020-09-02 | 25208.0 | 1664.0 | view text |
| cord-333381-wz70o9tt | Liu, Shao | Providing pharmacy services during the coronavirus pandemic | 2020-03-28 | nan | nan | view text |
| cord-330380-wnbyy1gk | Liu, Tingting | Applying high-performance computing in drug discovery and molecular simulation | 2016-01-11 | 8570.0 | 411.0 | view text |
| cord-299424-qy3lccjq | MUBAGWA, Kanigula | Chloroquine cardiac effects and toxicity.A short update. | 2020-06-19 | nan | nan | view text |
| cord-344934-m0q7rm6z | Mahapatra, Sovesh | Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking | 2020-04-07 | nan | nan | view text |
| cord-274474-u2fdicgz | Majumder, Joydeb | Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus | 2020-10-13 | 10098.0 | 634.0 | view text |
| cord-130351-w9mij6c6 | Mamidala, Estari | In silico identification of clinically approved medicines against the main protease of SARS-CoV-2, causative agent of covid-19 | 2020-04-25 | nan | nan | view text |
| cord-276886-vcmkz8lh | Mandsberg, Nikolaj Kofoed | Orally ingestible medical devices for gut engineering | 2020-05-13 | nan | nan | view text |
| cord-337738-2qck1j1w | Martin, Jennifer H. | Buying time: Drug repurposing to treat the host in COVID‐19H | 2020-06-23 | nan | nan | view text |
| cord-334170-85x5vmyi | Masoudi-Sobhanzadeh, Yosef | Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm | 2020-07-16 | 6507.0 | 383.0 | view text |
| cord-034406-i1hbx3pz | Matthews, Abigail A. | Developing inhaled protein therapeutics for lung diseases | 2020-10-30 | nan | nan | view text |
| cord-309025-jo0rqy3y | Maurya, Priyanka | Inhalable hybrid nanocarriers for respiratory disorders | 2020-09-18 | nan | nan | view text |
| cord-253115-ekgdsv4f | Mehta, Meenu | Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases | 2019-08-01 | 7317.0 | 457.0 | view text |
| cord-275828-c6d6nk7x | Mikasa, Keiichi | JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy – The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG | 2016-07-31 | 39672.0 | 2522.0 | view text |
| cord-258128-qtmjgrml | Mirjalili, Mahtabalsadat | Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen | 2020-07-03 | nan | nan | view text |
| cord-214795-8jweuq50 | Mongia, Aanchal | DeepVir -- Graphical Deep Matrix Factorization for"In Silico"Antiviral Repositioning: Application to COVID-19 | 2020-09-22 | 6420.0 | 369.0 | view text |
| cord-232446-vvb2ffhv | Mongia, Aanchal | A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials | 2020-07-03 | 7123.0 | 382.0 | view text |
| cord-268088-y4vg7frb | Montané, Xavier | Current Perspectives of the Applications of Polyphenols and Flavonoids in Cancer Therapy | 2020-07-23 | 11101.0 | 581.0 | view text |
| cord-348245-pf5mlzrw | Moura-Neto, José A. | Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function | 2020-08-26 | 962.0 | 57.0 | view text |
| cord-317993-012hx4kc | Movia, Dania | Preclinical Development of Orally Inhaled Drugs (OIDs)—Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models? | 2020-07-24 | 6885.0 | 369.0 | view text |
| cord-315918-12rbbe8c | Mukherjee, Pulok K. | Antiviral Evaluation of Herbal Drugs | 2019-06-21 | 12776.0 | 660.0 | view text |
| cord-020766-0gacqii4 | Murthy, Sreekant | Nanotechnology: Towards the detection and treatment of inflammatory diseases | 2006 | nan | nan | view text |
| cord-287758-da11ypiy | Mônica Vitalino de Almeida, Sinara | COVID-19 therapy: what weapons do we bring into battle? | 2020-09-10 | nan | nan | view text |
| cord-263074-qxiynbl2 | Nabi, Bushra | Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention | 2020-05-16 | nan | nan | view text |
| cord-256852-lrz17bdx | Nayyar, Gaurvika M. L. | Responding to the Pandemic of Falsified Medicines | 2015-06-03 | 4208.0 | 201.0 | view text |
| cord-264779-71s7e18i | Neumann, Natalie R. | Medical Toxicology and COVID-19: Our Role in a Pandemic | 2020-04-30 | nan | nan | view text |
| cord-102823-zult69f2 | Nguyen, Thin | GraphDTA: Predicting drug–target binding affinity with graph neural networks | 2020-10-02 | 4962.0 | 283.0 | view text |
| cord-299400-j18pj11d | Norinder, Ulf | Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19 | 2020-07-30 | 5310.0 | 251.0 | view text |
| cord-258614-7unadw41 | Ogidigo, Joyce Oloaigbe | Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach | 2020-10-25 | 8459.0 | 416.0 | view text |
| cord-349682-kpg0vley | Ojha, Probir Kumar | Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to | 2020-09-02 | nan | nan | view text |
| cord-317971-kuwargnp | Opatz, Till | Thoughts on What Chemists Can Contribute to Fighting SARS‐CoV‐2 – A Short Note on Hand Sanitizers, Drug Candidates and Outreach | 2020-05-08 | nan | nan | view text |
| cord-033723-jy5fdsp9 | Orhobor, Oghenejokpeme I. | Generating Explainable and Effective Data Descriptors Using Relational Learning: Application to Cancer Biology | 2020-09-19 | 4013.0 | 229.0 | view text |
| cord-292041-a65kfw80 | Orienti, Isabella | Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19 | 2020-05-27 | 6110.0 | 334.0 | view text |
| cord-285603-f4572w5m | Ortega, Joseph T. | Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis | 2020-06-24 | 5994.0 | 348.0 | view text |
| cord-265699-0socw0hp | Ortega, Miguel Ángel | Dendrimers and Dendritic Materials: From Laboratory to Medical Practice in Infectious Diseases | 2020-09-14 | nan | nan | view text |
| cord-354006-j1y42oxu | Ozdemir, Vural | Shifting emphasis from pharmacogenomics to theragnostics | 2006 | nan | nan | view text |
| cord-261311-j6bmgmhz | Parreiras Martins, Maria Auxiliadora | Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview | 2020-07-31 | 4307.0 | 206.0 | view text |
| cord-332038-icyut3xa | Pillaiyar, Thanigaimalai | A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery | 2020-04-02 | nan | nan | view text |
| cord-001470-hn288o97 | Pivette, Mathilde | Drug sales data analysis for outbreak detection of infectious diseases: a systematic literature review | 2014-11-18 | 4423.0 | 260.0 | view text |
| cord-295807-68sukdb1 | Quade, Bianca N. | The therapeutic importance of acid-base balance | 2020-10-09 | nan | nan | view text |
| cord-302312-1pm17l5d | Quinteros, Daniela A. | Therapeutic use of monoclonal antibodies: general aspects and challenges for drug delivery | 2017-03-31 | nan | nan | view text |
| cord-293860-6kz0iws6 | Qutayba Almerie, Muhammad | The Association between Obesity and Poor Outcome after COVID-19 Indicates a Potential Therapeutic Role for Montelukast | 2020-05-27 | nan | nan | view text |
| cord-264867-ezsy76mx | Rahman, Hamidur | The recent advancement of low-dimensional nanostructured materials for drug delivery and drug sensing application: A brief review | 2020-09-30 | nan | nan | view text |
| cord-328705-024y5k72 | Rahman, Md. Mahbubur | Virtual screening, molecular dynamics and structure–activity relationship studies to identify potent approved drugs for Covid-19 treatment | 2020-07-21 | nan | nan | view text |
| cord-199630-2lmwnfda | Ray, Sumanta | Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs | 2020-07-05 | nan | nan | view text |
| cord-009763-44fexcpt | Reddy, Mynampati Akshitha | Internet-of-Things-Enabled Dual-Channel Iontophoretic Drug Delivery System for Elderly Patient Medication Management | 2020-03-01 | 5226.0 | 331.0 | view text |
| cord-351222-9bfchw4u | Rollinger, Judith M. | Virtual screening for the discovery of bioactive natural products | 2008 | nan | nan | view text |
| cord-325315-m3do6t1j | Rossi, Carlo Maria | A case report of toxic epidermal necrolysis (TEN) in a patient with COVID-19 treated with hydroxychloroquine: are these two partners in crime? | 2020-10-06 | 2540.0 | 152.0 | view text |
| cord-315702-pn8247j2 | Sahakijpijarn, Sawittree | Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing | 2020-09-22 | nan | nan | view text |
| cord-321230-b5a1z14w | Samji, Hasina | Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada | 2020-10-19 | nan | nan | view text |
| cord-262442-kjgpriow | Scalia, Santo | Quercetin solid lipid microparticles: A flavonoid for inhalation lung delivery | 2013-05-13 | 5525.0 | 310.0 | view text |
| cord-309871-y17puao2 | Scherrmann, JM. | Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy | 2020-06-12 | 3905.0 | 189.0 | view text |
| cord-006479-iaocovf2 | Schreiber, J. | Medikamenteninduzierte parenchymatöse Lungenerkrankungen | 2009-08-01 | 1825.0 | 214.0 | view text |
| cord-342756-rgm9ffpk | Senger, Mario Roberto | COVID-19: molecular targets, drug repurposing and new avenues for drug discovery | 2020-10-02 | 16108.0 | 1024.0 | view text |
| cord-348102-k0s9j9sz | Silvestris, Nicola | On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents | 2020-07-21 | nan | nan | view text |
| cord-270516-9ol1209i | Singh, Bhupinder | Functionalized carbon nanotubes and their promising applications in therapeutics and diagnostics | 2016-04-15 | nan | nan | view text |
| cord-017062-dkw2sugl | Singh, Indu | Delivery Systems for Lymphatic Targeting | 2013-10-08 | nan | nan | view text |
| cord-321379-7bpl5n3j | Singh, Sweta | Coronavirus disease 2019 drug discovery through molecular docking | 2020-06-03 | nan | nan | view text |
| cord-336554-n8n5ii5k | Singh, Thakur Uttam | Drug repurposing approach to fight COVID-19 | 2020-09-05 | 13032.0 | 690.0 | view text |
| cord-298369-66ifwtlp | Smith, Sherri A. | Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein | 2018-12-28 | 10621.0 | 491.0 | view text |
| cord-007798-9ht7cqhu | Smith, Silas W. | Drugs and pharmaceuticals: management of intoxication and antidotes | 2010-02-25 | 22555.0 | 1371.0 | view text |
| cord-279106-3ffa9djf | Syatila Ab Ghani, Nur | Side chain similarity comparisons for integrated drug repositioning and potential toxicity assessments in epidemic response scenarios: the case for COVID-19 | 2020-10-21 | nan | nan | view text |
| cord-352579-ndcbmgfj | Takahashi, Takuto | Pharmacogenomics of COVID-19 therapies | 2020-08-18 | nan | nan | view text |
| cord-308994-4nljzm8a | Tang, Zhongmin | Insights from nanotechnology in COVID-19 treatment | 2020-11-04 | 3239.0 | 177.0 | view text |
| cord-331633-ix5un6c9 | Teixeira, Maria C. | Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs) | 2020-03-20 | nan | nan | view text |
| cord-281561-r10y2sgb | Tiwari, Nidhi | Novel β-Coronavirus (SARS-CoV-2): Current and Future Aspects of Pharmacological Treatments | 2020-08-27 | nan | nan | view text |
| cord-354180-6esn3t2b | Tyndall, Mark | Safer opioid distribution in response to the COVID-19 pandemic | 2020-07-27 | 4223.0 | 221.0 | view text |
| cord-263312-x7f0hn7f | Tzelepis, Ilias | Drosophila melanogaster: a first step and a stepping-stone to anti-infectives | 2013-08-28 | nan | nan | view text |
| cord-277535-u283k70i | Vaja, Rakesh | Drugs and the liver | 2020-09-22 | nan | nan | view text |
| cord-003118-58ta20fg | Van Norman, Gail A. | Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies | 2018-06-25 | 2205.0 | 109.0 | view text |
| cord-284648-yznlgzir | Varanko, Anastasia | Recent trends in protein and peptide-based biomaterials for advanced drug delivery | 2020-08-29 | 33501.0 | 1732.0 | view text |
| cord-263803-0n41gylj | Villoutreix, Bruno O. | Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders | 2020-06-25 | nan | nan | view text |
| cord-303237-xvba5mqq | Wang, L.-Y. | Genetic Profiles in Pharmacogenes Indicate Personalized Drug Therapy for COVID-19 | 2020-03-30 | nan | nan | view text |
| cord-103876-2rg2qtdq | Watkins, Laura C. | Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics | 2020-06-20 | nan | nan | view text |
| cord-304506-6el2ryl8 | Watkins, Laura C. | Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics | 2020-09-16 | 6140.0 | 277.0 | view text |
| cord-326922-bajpr5a2 | Watson, C. James | Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors | 2020-11-02 | 7095.0 | 417.0 | view text |
| cord-289382-bnl9i9oy | Wright, Gerard D | Q&A: Antibiotic resistance: where does it come from and what can we do about it? | 2010-09-20 | nan | nan | view text |
| cord-000204-hd12p867 | Wu, Han-Chung | Peptide-Mediated Liposomal Drug Delivery System Targeting Tumor Blood Vessels in Anticancer Therapy | 2010-05-05 | 4433.0 | 217.0 | view text |
| cord-267979-k70gnrdw | Yıldız-Peköz, Ayca | Advances in Pulmonary Drug Delivery | 2020-09-23 | 3257.0 | 159.0 | view text |
| cord-313268-j51zyodw | Zeng, Xiangxiang | Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning | 2020-07-12 | nan | nan | view text |
| cord-178783-894gkrsk | Zhang, Rui | Drug Repurposing for COVID-19 via Knowledge Graph Completion | 2020-10-19 | nan | nan | view text |
| cord-317435-4yuw7jo3 | Zhou, Yadi | Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 | 2020-03-16 | nan | nan | view text |
| cord-353572-b4mdiont | Zhou, Yadi | Network-based Drug Repurposing for Human Coronavirus | 2020-02-05 | 6871.0 | 390.0 | view text |
| cord-284208-8fsqgkw5 | Zolla, Lello | Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteins | 2008-11-07 | nan | nan | view text |
| cord-002774-tpqsjjet | nan | Section II: Poster Sessions | 2017-12-01 | nan | nan | view text |
| cord-006226-fn7zlutj | nan | Abstracts of the 4th annual meeting of the German Society of Clinical Pharmacology and Therapy: Hannover, 14–17 September 1994 | 1994 | nan | nan | view text |
| cord-006229-7yoilsho | nan | Abstracts of the 82(nd) Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 18(th) Annual Meeting of the Network Clinical Pharmacology Germany (VKliPha) in cooperation with the Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V. (AGAH) | 2016-02-06 | 133493.0 | 6804.0 | view text |
| cord-014687-0am4l5ms | nan | SPR 2012 | 2012-03-29 | 98592.0 | 5600.0 | view text |
| cord-014875-xhzxhwgo | nan | Book Reviews | 2003 | 7144.0 | 338.0 | view text |
| cord-015334-8p124rwp | nan | ESCP 36th European Symposium on Clinical Pharmacy ‘Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience’, Istanbul, Turkey 25–27 October 2007; Abstracts | 2008-06-11 | 51143.0 | 3291.0 | view text |
| cord-024833-e6vcf4un | nan | Forum | 2019-12-19 | 8110.0 | 391.0 | view text |
| cord-265848-afkeuwup | nan | Chapter 2 Emergency Management of Poisoning | 2007-12-31 | 27412.0 | 1589.0 | view text |
| cord-350571-6tapkjb6 | nan | 45th ESCP-NSF international symposium on clinical pharmacy: clinical pharmacy tackling inequalities and access to health care. Oslo, Norway, 5–7 October 2016 | 2017-01-10 | 106013.0 | 6203.0 | view text |
| cord-350703-vrqltz3s | nan | ISAR News | 2016-01-31 | nan | nan | view text |
| cord-289321-ahl46ql9 | van Buuren, Nicholas | Transmission genetics of drug-resistant hepatitis C virus | 2018-03-28 | 7817.0 | 394.0 | view text |